Proteostasis Therapeutics, Inc.

117 articles about Proteostasis Therapeutics, Inc.

• Proteostasis Therapeutics, Inc. Presents Promising Preclinical Data at the 27th Annual North American Cystic Fibrosis Conference

  10/18/2013

• Proteostasis Therapeutics, Inc. Receives Funding From The Michael J. Fox Foundation for Parkinson's Disease Research

  6/6/2013

• Proteostasis Therapeutics, Inc. Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference

  5/21/2013

• Proteostasis Therapeutics, Inc. Presents Data at 11th International Conference on Alzheimer’s and Parkinson’s Diseases

  3/8/2013

• Proteostasis Therapeutics, Inc. Presents Data at Two Scientific Conferences for Lead Programs in Cystic Fibrosis and Parkinson's Disease

  10/18/2012

• Proteostasis Therapeutics, Inc. Presents Data at Multiple Scientific Conferences Highlighting Novel Approach to Neurodegenerative Diseases and Cystic Fibrosis

  8/14/2012

• Proteostasis Therapeutics, Inc. Announces Expansion of Collaboration With The Scripps Research Institute to Broaden Cystic Fibrosis Program

  7/26/2012

• Proteostasis Therapeutics, Inc. Announces Collaboration With Cystic Fibrosis Foundation Therapeutics, Inc.

  5/7/2012

• Proteostasis Therapeutics, Inc. Announces Appointment of Mark J. Enyedy as Chief Executive Officer

  10/20/2011

• Harvard University’s Alfred Goldberg, Ph.D., Daniel Finley, Ph.D., and Randall King, M.D., Ph.D., Named Harvard University Scientific Co-Founders

  5/5/2011

• Proteostasis Therapeutics, Inc. Licenses Novel Protein Clearance Targets, Compounds from Harvard University

  4/26/2011

• Proteostasis Therapeutics, Inc. Announces Additions of Key Executives; Peter H. Reinhart Joins as CSO and Gregory P. Licholai is Appointed COO

  3/25/2010

• Proteostasis Therapeutics, Inc., a Rich Boston Biotech with San Diego Ties, Grows to Pursue Diseases of Aging

  2/18/2010

• Proteostasis Therapeutics, Inc. Exclusively Licenses Discoveries Related to Unfolded Protein Response from Ron Laboratory at New York University

  1/7/2010

• Proteostasis Therapeutics, Inc. Scientific Founders Publish Paper in Cell Establishing Role of the Proteostasis Network in Alzheimer's Disease

  12/15/2009

• GeneGo, Inc. Licenses MetaCore to Proteostasis Therapeutics, Inc.

  9/8/2009

• Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs

  8/25/2008